Afuco™ Anti-Human ACVR2A ADCC Therapeutic Antibody, ADCC Enhanced

Anti-ACVR2A ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Molecules having activin or ActRIIa antagonist activity ("activin antagonists" and "ActRIIa antagonists") can be used to increase bone density, promote bone growth, and/or increase bone strength.
Supplier Creative Biolabs
Product # AFC-010CL
Pricing Inquiry
Host Mouse
Target ACVR2A
Species Reactivity Human
Type ADCC enhanced antibody
Storage ≤1 year at -20°C.
Feedback